Bathocuproine

Bathocuproine

SCHEMBL29356702

Cc1cc(-c2ccccc2)c2ccc3c(-c4ccccc4)cc(C)nc3c2n1

nearest known ligand 0.48

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CRHR1 P34998 1/20 0.48
KDM4E B2RXH2 5/20 0.47
ALDH1A1 P00352 5/20 0.47
HPGD P15428 3/20 0.47
HSD17B10 Q99714 3/20 0.47
MAPT P10636 6/20 0.43
L3MBTL1 Q9Y468 3/20 0.43
LMNA P02545 2/20 0.43
RAB9A P51151 3/20 0.42
NPC1 O15118 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
CYP1A2 P05177 1/20 0.42
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
TP53 P04637 1/20 0.41
ALOX15 P16050 1/20 0.41
TSHR P16473 1/20 0.41
MAPK1 P28482 1/20 0.41
GFER P55789 1/20 0.41
RECQL P46063 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bathocuproine SCHEMBL20526077 1.00 CRHR1 (0.48) CRHR1KDM4EALDH1A1HPGDHSD17B10
Bathocuproine SCHEMBL36914 1.00 CRHR1 (0.48) CRHR1KDM4EALDH1A1HPGDHSD17B10
Bathocuproine SCHEMBL29351092 1.00 CRHR1 (0.48) CRHR1KDM4EALDH1A1HPGDHSD17B10
Bathocuproine SCHEMBL28523242 0.98 CRHR1 (0.47) CRHR1KDM4EALDH1A1HPGDHSD17B10
Bathocuproine SCHEMBL8203658 0.98 CRHR1 (0.47) CRHR1KDM4EALDH1A1HPGDHSD17B10
Bathocuproine SCHEMBL38659029 0.98 CRHR1 (0.47) CRHR1KDM4EALDH1A1HPGDHSD17B10
Bathocuproine SCHEMBL28202746 0.98 CRHR1 (0.47) CRHR1KDM4EALDH1A1HPGDHSD17B10
Bathocuproine SCHEMBL5398100 0.98 CRHR1 (0.47) CRHR1KDM4EALDH1A1HPGDHSD17B10
Bathocuproine SCHEMBL29080447 0.98 CRHR1 (0.47) CRHR1KDM4EALDH1A1HPGDHSD17B10
Bathocuproine SCHEMBL27915438 0.98 CRHR1 (0.47) CRHR1KDM4EALDH1A1HPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 345 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4684611-A1 PEROVSKITE-BASED PHOTOVOLTAIC CELLS AND PREPARATION PROCESS THEREOF ENI S.p.A. (IT) 2026-01-28 EP claimed
US-20260015743-A1 MEDIATED HYDROGEN ANODE FOR USE IN REDUCTIVE ELECTROSYNTHESIS WISCONSIN ALUMNI RES FOUND (US) 2026-01-15 US claimed
US-20250331356-A1 PEROVSKITE BASED PHOTOVOLTAIC CELLS AND PROCESS FOR PREPARING THE SAME SUNXT S.R.L. (IT) 2025-10-23 US claimed
EP-4632063-A2 COPPER LOSS MITIGATION GENENTECH, INC. (US) 2025-10-15 EP claimed
EP-4136211-B1 COPPER LOSS MITIGATION GENENTECH INC (US) 2025-07-09 EP claimed
EP-4537641-A1 PEROVSKITE BASED PHOTOVOLTAIC CELLS AND PROCESS FOR PREPARING THE SAME Eni S.p.A. (IT) 2025-04-16 EP claimed
US-12245495-B2 Backbone-engineered highly efficient polymer hole transporting materials, inverted perovskite solar cells made therefrom, and manufacturing methods therefor CITY UNIVERSITY OF HONG KONG (HK) 2025-03-04 US claimed
EP-3012279-B1 COPOLYMER AND ORGANIC SOLAR CELL COMPRISING SAME LG CHEMICAL LTD (KR) 2025-02-12 EP claimed
WO-2025025691-A1 SOLAR CELL AND MANUFACTURING METHOD THEREFOR, PHOTOVOLTAIC MODULE, AND PHOTOVOLTAIC DEVICE 宁德时代新能源科技股份有限公司 2025-02-06 WO claimed
WO-2025025546-A1 SOLAR CELL AND PREPARATION METHOD THEREFOR, PHOTOVOLTAIC MODULE AND PHOTOVOLTAIC DEVICE 宁德时代新能源科技股份有限公司 2025-02-06 WO claimed
WO-2024194758-A1 PEROVSKITE-BASED PHOTOVOLTAIC CELLS AND PREPARATION PROCESS THEREOF ENI S.P.A. (IT) 2024-09-26 WO claimed
WO-2024174565-A1 PREPARATION METHOD AND APPLICATION OF ULTRA-RAPID AND HIGH-SENSITIVITY MULTICHANNEL NOVEL CORONAVIRUS NUCLEIC ACID RAMAN ANALYSIS CHIP 华东师范大学 2024-08-29 WO claimed
WO-2024104104-A1 CHARGE TRANSFER RAMAN ENHANCED SUBSTRATE MATERIAL BASED ON PLASMON RESONANCE ENHANCEMENT, PREPARATION, AND USE THEREOF 华东师范大学 2024-05-23 WO claimed
WO-2023238080-A1 PEROVSKITE BASED PHOTOVOLTAIC CELLS AND PROCESS FOR PREPARING THE SAME ENI S.P.A. (IT) 2023-12-14 WO claimed
EP-4002505-B1 FUNCTIONALIZED IONIC LIQUIDS AS STABILIZERS FOR PEROVSKITE SOLAR CELLS TOYOTA MOTOR CO LTD (JP) 2023-11-01 EP claimed
EP-4136211-A1 COPPER LOSS MITIGATION Genentech, Inc. (US) 2023-02-22 EP claimed
EP-3719099-B1 PHOSPHORESCENT MATERIALS UNIVERSAL DISPLAY CORP (US) 2022-09-14 EP claimed
EP-4006021-A1 TRIPHENYLAMINE FUNCTIONALIZED OLIGOTHIOPHENES: STABLE AND LOW COST HOLE-TRANSPORTING MATERIALS FOR HIGH PERFORMANCE PEROVSKITE SOLAR CELLS Toyota Jidosha Kabushiki Kaisha (JP) 2022-06-01 EP claimed
EP-4002505-A1 FUNCTIONALIZED IONIC LIQUIDS AS STABILIZERS FOR PEROVSKITE SOLAR CELLS TOYOTA JIDOSHA KABUSHIKI KAISHA (JP) 2022-05-25 EP claimed
EP-3537492-B1 QUANTUM DOT DEVICE AND ELECTRONIC DEVICE SAMSUNG ELECTRONICS CO LTD (KR) 2022-04-27 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260015743-A1 MEDIATED HYDROGEN ANODE FOR USE IN REDUCTIVE ELECTROSYNTHESIS HAO2, HACL2, HVCN1 CRHR1 2817/4885KDM4E 3823/4885ALDH1A1 246/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.